Ranbaxy Laboratories Ltd.



Ranbaxy Laboratories Ltd. was an Indian pharmaceutical company that was founded in 1961 by Ranbir Singh and Gurbax Singh. The company was headquartered in Gurgaon, Haryana, India. In 2014, Ranbaxy Laboratories was acquired by Sun Pharmaceutical Industries, another leading Indian pharmaceutical company.

History:
Ranbaxy Laboratories started as a small pharmaceutical company in India and over the years, it grew to become one of the largest generic drug manufacturers in the world. The company expanded its operations globally and had a presence in over 150 countries. In 2008, Ranbaxy Laboratories was embroiled in a major controversy over the quality of its drugs, which led to a significant decline in the company's financial performance and reputation.

Profile:
Ranbaxy Laboratories specialized in the manufacturing and marketing of generic drugs and had a strong focus on research and development. The company had a portfolio of over 500 products and had a presence in several therapeutic categories, including cardiovascular, anti-infective, respiratory, and central nervous system, among others. The company also had a significant presence in emerging markets, including Africa, Asia, and Latin America.

Products:
Ranbaxy Laboratories offered a wide range of generic drugs, including prescription and over-the-counter medications. Some of the popular products offered by the company included Atorvastatin (a cholesterol-lowering medication), Ciprofloxacin (an antibiotic), and Amoxicillin (an antibiotic).

Financials:
As a private company, Ranbaxy Laboratories did not disclose its financial information publicly. However, the company was one of the leading pharmaceutical companies in India and had a global presence with operations in over 150 countries. In 2014, the company was acquired by Sun Pharmaceutical Industries for $3.2 billion.

Despite the controversies surrounding the company, Ranbaxy Laboratories was recognized for its contribution to the pharmaceutical industry and had received several awards and recognitions over the years. The company was committed to sustainable and ethical business practices and had a strong focus on research and development to deliver high-quality, affordable healthcare products to patients around the world.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.

The Company is ranked amongst the top ten global generic companies and has a presence in 23 of the top 25 pharma markets of the world. It exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries.

Most of Ranbaxy's products are manufactured by license from foreign pharmaceutical developers, though a significant percentage of their products are off-patent drugs that are manufactured and distributed without licensing from the original manufacturer because the patents on such drugs have expired.

Ranbaxy Laboratories Limited
Corporate Office
Plot 90, Sector 32,
Gurgaon -122001 (Haryana), INDIA
Ph: 91- 124- 4135000
Fax: 91-124-4135001

Web : http://www.ranbaxy.com/